The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
400 jobs Number of planned job creations
Announcement Date
18 October 2007
Employment effect (start)
Foreseen end date
Description
Ivax Pharmaceuticals (formely known as Galena), a subsidiary of the multinational pharmaceutical company Teva Pharmaceutical Industries, announced on 11 March 2008 that is to create approximately 400 new jobs in Opava with the expansion of its exisiting site. The firm currently employs over 1,100 people at its Opava plant, and the expansion will involve the construction of a new production facility at its site and an investment of USD 100 billion. The new facility will produce tablets and gelatine capsules. As of March 2008, there is no information on when employment at the new site will commence and when the new jobs will be created by. This is an update of media news released on 18 October 2007.
Sources
11 March 2008: Hospodárske noviny
18 October 2007: Hospodárske noviny
Citation
Eurofound (2007), Ivax Pharmaceuticals, Business expansion in Czechia, factsheet number 65915, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65915.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
